shadow_tr

John J. Schmieg, MD, PHD

John J. Schmieg, M.D., Ph.D.


Assistant Professor


Education:

  • B.A., Summa cum Laude, Molecular Biology and Anthropology, Vanderbilt University, Nashville, TN, 1994-1998

  • M.D., Ph.D., Medical Scientist Training Program, New York University School of Medicine, New York, NY, 1998-2006

Postgraduate Training and Fellowship Appointments:

  • Resident, Anatomic and Clinical Pathology, The Johns Hopkins Hospital, Baltimore, MD, 2006-2010

  • Clinical Fellow, Hematopathology, The Johns Hopkins Hospital, Baltimore, MD, 2010-2011

Specialty Certification:

  • Diplomate of The American Board of Pathology in combined Anatomic and Clinical Pathology, 2010


Awards, Honors, and Memberships in Honor Societies:

  • Dean's List Every Semester, 1994-1998

  • Howard Hughes Summer Research Fellowship Recipient, Vanderbilt University, 1996

  • Summa cum Laude Honors Recipient, Vanderbilt University, 1998

  • Recipient of the American Society of Tropical Medicine and Hygiene Molecular, Cellular, and Immunoparasitology Scientific Award, 2003

  • Recipient of Medicine Clerkship Award for Outstanding Essay in Pathophysiology of Disease, New York University School of Medicine, 2005

  • Alpha Omega Alpha, 2006


Membership in Professional and Scientific Societies:

  • United States and Canadian Academy of Pathology, 2006-Present

  • College of American Pathologistsm, 2006-Present

  • American Society for Clinical Pathology, 2006-Present


Publications:

  1. Schmieg J, Yang G, Franck RW, Tsuji M.  2010.  A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer.  J Biomed Biotechnol, 2010: 283612, 11 pages

  2. Visaya JM, Chu EA, Schmieg J, Iding JS, Koch WM.  2009.  Pathology quiz case 1. Epithelial-myoepithelial carcinoma (EMC).  Arch Otolaryngol Head Neck Surg, 135: 832

  3. Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M.  2005.  Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion.  Proc Natl Acad Sci U S A, 102: 1127-1132.

  4. Chen G, Schmieg J, Tsuji M, Franck RW.  2004.  Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis.  Org Lett, 2004 6: 4077-4080.

  5. Yang G, Schmieg J, Tsuji M, Franck RW.  2004.  The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity.  Angew Chem Int Ed Engl, 43: 3818-3822.

  6. Schmieg J, Yang G, Franck RW, Tsuji M.  2003.  Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.  J Exp Med, 198: 1631-1641.

  7. Schmieg J, Gonzalez-Aseguinolaza G, Tsuji M.  2003.  The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites.  Microbes Infect, 5: 499-506.

  8. Gonzalez-Aseguinolaza G, Schmieg J, Berraondo P, Ochoa L, Tsuji M.  2002.  The involvement of CD1d-restricted NKT cells in infectious processes.  Inmunologia, 21: 145-155.

  9. Bruna-Romero O*, Schmieg J*, Del Val M, Buschle M, Tsuji M.  2002.  The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.  J Immunol, 170: 3195-3203 (* co-first authors).

  10. Li S, Scuderi G, Furman BD, Bhattacharyya S, Schmieg JJ, Insall JN.  2002.  Assessment of backside wear from the analysis of 55 retrieved tibial inserts.  Clin Orthop Relat Res, 404: 75-82.

  11. Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M.  2002.  Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.  J Exp Med, 195: 617-624.


Abstracts and Presentations:

  1. 52nd annual American Society of Tropical Medicine and Hygiene meeting. Alpha-C-galactosylceramide: a novel natural killer T cell ligand with Th1 polarizing activity. Schmieg, J, 12/2003.

  2. 7th annual Woods Hole Immunoparasitology meeting. Alpha-C-galactosylceramide: a novel natural killer T cell ligand with Th1 polarizing activity, Schmieg, J, 05/2003.

  3. 45th annual Orthopaedic Research Society meeting.  Assessment of backside polyethylene wear in three different metal backed total knee designs.  Furman, BD, Schmieg JJ, Bhattacharyya S, Li S, 01/1999.

  4. 45th annual Orthopaedic Research Society meeting.  An independent evaluation of the mechanical, chemical, and fracture properties of ultra high molecular weight polyethylene cross linked by 34 different conditions.  Gillis, AM, Schmieg JJ, Bhattacharyya S, Li, S, 01/1999.

  5. 25th annual Society for Biomaterials meeting.  The determination of “backside wear” in retrieved tibial inserts with four different locking mechanisms.  Furman, BD, Schmieg JJ, Bhattacharyya S, Li, S, 01/1999.

  6. 25th annual Society for Biomaterials meeting.  Wear and damage to the post in posterior stabilized total knee replacements: an unexpected source of polyethylene debris.  Furman, BD, Gillis AM, Schmieg JJ, Bhattacharyya S, Li, S, 01/1999.


Dept. of Pathology & Laboratory Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 504-988-5224 tulpath@tulane.edu